StonvexLoading…
StonvexStonvexStonvexCore line items from EHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.94B | $5.37B | $4.80B | $4.35B |
Operating Income | $953.00M | $749.60M | $607.20M | $539.50M |
Net Income | $566.20M | $455.70M | $352.00M | $271.00M |
EPS (Diluted) | $5.54 | $4.46 | $3.47 | $2.70 |
Total Assets | $7.09B | $6.53B | $6.10B | $5.64B |
Total Liabilities | $3.81B | $3.69B | $3.81B | $3.77B |
Cash & Equivalents | $72.20M | $85.40M | $69.10M | $21.80M |
Free Cash Flow OCF − CapEx | $439.20M | $360.30M | $267.70M | $141.00M |
Shares Outstanding | 102.20M | 102.20M | 101.30M | 100.40M |